Showing 1 - 9 results of 9 for search 'deployment of COVID-19 vaccines', query time: 0.08s Refine Results
  1. 1

    Deployment and uptake of COVID-19 vaccines for refugees and migrants in regular and irregular situations: a mixed-method multicountry study by Biraj Man Karmacharya, Karl Blanchet, Jai K Das, Laetitia Nyirazinyoye, Maria Midea M Kabamalan, Nguyen Toan Tran, Zahra A Padhani, Anjali Joshi, Seyed-Moeen Hosseinalipour, Enrique Teran, Pierina Benavente, Vinay N Kampalath, Moussa Lonkila Zan, Elżbieta Anna Czapka, Cheryl Martens, Vicente B Jurlano

    Published 2025-02-01
    “…Phase 2 (June–August 2022) included a cross-sectional study among refugees and migrants in regular (MIRS) and irregular situations (MIIS) and used descriptive analysis and a COVID-19 Vaccine Equity Index (CVEI).Results A total of 1378 individuals responded to the survey (43.8% MIRS, 31.2% MIIS and 25% refugees). 87% reported receiving at least one dose of the COVID-19 vaccine. …”
    Get full text
    Article
  2. 2

    Protect or prevent? A practicable framework for the dilemmas of COVID-19 vaccine prioritization. by Raghu Arghal, Harvey Rubin, Shirin Saeedi Bidokhti, Saswati Sarkar

    Published 2025-01-01
    “…Determining COVID-19 vaccination strategies presents many challenges in light of limited vaccination capacity and the heterogeneity of affected communities. …”
    Get full text
    Article
  3. 3

    COVID-19 vaccine hesitancy among marginalized populations in the U.S. and Canada: Protocol for a scoping review. by Peter A Newman, Luke Reid, Suchon Tepjan, Sophia Fantus, Kate Allan, Thabani Nyoni, Adrian Guta, Charmaine C Williams

    Published 2022-01-01
    “…<h4>Introduction</h4>Despite the development of safe and highly efficacious COVID-19 vaccines, extensive barriers to vaccine deployment and uptake threaten the effectiveness of vaccines in controlling the pandemic. …”
    Get full text
    Article
  4. 4

    Modifying non-coding regions of linear DNA vaccines to explore the interplay of expression and inflammation in immunogenicity by David C. Stirling, Maria de Miguel Ferrer, Sungwon Kim, Madina Wane, Daniel Kysh, Lisa J. Caproni, John S. Tregoning

    Published 2025-12-01
    “…The COVID-19 pandemic highlighted the need for rapidly deployable, flexible vaccine platforms; particularly RNA which is now being explored for several other pathogens. …”
    Get full text
    Article
  5. 5

    The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections by Keneth Iceland, Kasozi

    Published 2021
    “…With successive waves of COVID-19 emerging, strategies that mitigate against community transmission need to be implemented, including increased vaccination coverage. …”
    Get full text
    Article
  6. 6
  7. 7

    Inequalities in health behaviours during the COVID-19 pandemic – a commentary by Aleksandra Herbeć

    Published 2024-12-01
    “…The focus of the pandemic response has been on health protective behaviours (e.g. update of vaccinations, isolation, and use of face covering). Health behaviours and health behaviour change (such as changes in physical activity, diet and alcohol consumption) have been socio-demographically- patterned already before the COVID-19 pandemic. …”
    Get full text
    Article
  8. 8

    Effect of Double Masking with Silk or Cotton Over-masks on the Source Control Capabilities of a Surgical Mask by Adam F. Parlin, Mikhail Yermakov, Samuel M. Stratton, Susan R. Reutman, Theresa M. Culley, Patrick A. Guerra, Sergey A. Grinshpun

    Published 2022-04-01
    “…Abstract In spite of the remarkable progress made in the development of safe and effective vaccines against COVID-19, deployment of respiratory protective devices remains vital for mitigating the transmission of SARS-CoV-2 during the ongoing pandemic. …”
    Get full text
    Article
  9. 9

    Real-Time Pharmacovigilance: Transforming Population-Based Monitoring of Post-Approval Vaccine Safety Through Rapid Cycle Analysis (RCA)—A Review of the Published Literature by Sampada Gandhi, Michelle R. Iannacone, Andrea Leapley, Li Wang, Mwedusasa Mtenga, Muhammad Younus, Joanne Wu

    Published 2025-01-01
    “…Twelve (67%) aimed at signal detection and six (33%) conducted further signal evaluation. Over 60% examined COVID-19 vaccine safety, with half using VSD. Over 80% conducted the RCA weekly or monthly and about 78% of the studies used a database-specific historical comparator group. …”
    Get full text
    Article